Upcoming biologic agents for the treatment of rheumatic diseases

被引：45

作者：

Shanahan, JC ^{[1
]}

Moreland, LW ^{[1
]}

Carter, RH ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA

来源：

CURRENT OPINION IN RHEUMATOLOGY | 2003年 / 15卷 / 03期

关键词：

D O I：

10.1097/00002281-200305000-00009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The development of biologic agents has provided rheumatologists with a variety of new and effective treatment options. The success of early biologics, especially etanercept and infliximab for the treatment of rheumatoid arthritis, has spurred research into novel targets for the management of systemic inflammatory and autoimmune diseases. In addition, existing biologics approved for use in other diseases, such as rituximab, are now under study for the treatment of new indications. This article reviews ongoing research on the treatment of rheumatic diseases with new and existing biologic agents.

引用

页码：226 / 236

页数：11

共 50 条

[31] Treatment of chronic inflammatory diseases with biologic agents: Opportunities and risks for the elderly
Diaz-Borjon, Alejandro
Weyand, Cornelia M.
Goronzy, Jorg J.
[J]. EXPERIMENTAL GERONTOLOGY, 2006, 41 (12) : 1250 - 1255
[32] Treatment of inflammatory bowel diseases: focusing on biologic agents and new therapies
Song, Hyo Yeop
Seo, Geom Seog
[J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (09): : 605 - 613
[33] Pregnancy experience in women with rheumatic diseases exposed to biologic agents: Results from the BSR biologics register
Hyrich, K. L.
Watson, K. D.
Dixon, W. G.
Silman, A. J.
Symmons, D. P. M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 321 - 321
[34] Pregnancy experience in women with rheumatic diseases exposed to biologic agents: Results from the BSR biologics register
Hyrich, K. L.
Watson, K. D.
Dixon, W. G.
Silman, A. J.
Symmons, D. P. M.
[J]. RHEUMATOLOGY, 2006, 45 : I7 - I7
[35] Use of Biologic Agents in Ocular Manifestations of Rheumatic Disease
Kraus, Courtney L.
Culican, Susan M.
[J]. INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
[36] Prevalence Of Positive Tst In Patients With Rheumatic Diseases Candidates For biologic Agents In A High Tuberculosis Incidence Setting
Silva, D. R.
Garziera, G.
Otesbelgue, F.
Staub, F. L.
Palominos, P. E.
Brenol, C. V.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[37] Impact of biologic agents on infectious diseases
Saketkoo, Lesley Ann
Espinoza, Luis R.
[J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2006, 20 (04) : 931 - +
[38] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
Furst, D. E.
Breedveld, F. C.
Kalden, J. R.
Smolen, J. S.
Burmester, G. R.
Emery, P.
Keystone, E. C.
Schiff, M. H.
van Riel, P. L. C. M.
Weinblatt, M. E.
Weisman, M. H.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 2 - 15
[39] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Furst, D. E.
Breedveld, F. C.
Kalden, J. R.
Smolen, J. S.
Burmester, G. R.
Sieper, J.
Emery, P.
Keystone, E. C.
Schiff, M. H.
Mease, P.
van Riel, P. L. C. M.
Fleischmann, R.
Weisman, M. H.
Weinblatt, M. E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 2 - 22
[40] Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
Furst, D. E.
Keystone, E. C.
Fleischmann, R.
Mease, P.
Breedveld, F. C.
Smolen, J. S.
Kalden, J. R.
Braun, J.
Bresnihan, B.
Burmester, G. R.
De Benedetti, F.
Doerner, T.
Emery, P.
Gibofsky, A.
Kavanaugh, A.
Kirkham, B.
Schiff, M. H.
Sieper, J.
Singer, N.
Van Riel, P. L. C. M.
Weinblatt, M. E.
Weisman, M. H.
Winthrop, K.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 : 2 - 29

← 1 2 3 4 5 →